Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug policy: an oxymoron?

Jean Gray1

  • 1Dalhousie University, Halifax, Nova Scotia.

Healthcarepapers
|June 18, 2003
PubMed
Summary

Canadian healthcare policy struggles to keep pace with the pharmaceutical industry, creating inconsistencies in drug access. Re-examining pharmaceutical decision-making is crucial for equitable healthcare delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A woman in a man's world.

Clinical and investigative medicine. Medecine clinique et experimentale·2018
Same author

Voices leadership is all very well, but leaders need people to lead, says jean gray.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

Voices - The battle for reform of us health care rages on, writes Jean Gray.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

Voices.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

RCN breaks with other unions over pay.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016
Same author

Call for inquiry into 'spread of freemasonry' in nursing.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016

Area of Science:

  • Health Policy
  • Pharmaceutical Management
  • Canadian Healthcare System

Background:

  • Current Canadian healthcare policy faces challenges in effectively regulating pharmaceutical practices.
  • The pharmaceutical industry often outpaces policy development, leading to reactive rather than proactive governance.

Discussion:

  • Inconsistencies and ironies exist in Canadian healthcare delivery, particularly concerning drug policy.
  • Policy-makers frequently adopt a follower role due to the rapid evolution of pharmaceutical landscapes.

Key Insights:

  • The dynamic nature of the pharmaceutical industry necessitates a re-evaluation of current decision-making processes.
  • There is a critical need for a strategic approach to pharmaceutical policy to ensure alignment with healthcare goals.

Outlook:

  • A revised decision-making framework is essential to fulfill the promise of the Canada Health Act.
  • Future policy must proactively address pharmaceutical advancements to guarantee universal access to care.

Related Experiment Videos